Abstract-In response to endotoxemia induced by administration of lipopolysaccharide, a complex series of reactions occurs in mammalian tissues. During this inflammation response, cells produce different mediators, such as reactive oxygen species, a number of arachidonic acid metabolites, and cytokines. The reactive oxygen species thus generated have been suggested to produce tissue injury as a result of macromolecular damage or by interfering with regulatory processes. They may also act as important signaling molecules to induce redox-sensitive genes. We report here that transgenic mice overexpressing 2 major forms of human glutathione peroxidases (GPs), intra-and extracellular GP, are able to modulate host response during endotoxemic conditions. We show that these animals have a decreased hypotension and increased survival rate after administration of a high dosage of lipopolysaccharide. Overexpression of GPs alters vascular permeability and production of cytokines (interleukin-1 and tumor necrosis factor-␣) and NO, affects arachidonic acid metabolism, and inhibits leukocyte migration. These results suggest an important role for peroxides in pathogenesis during endotoxemia, and GPs, by regulating their level, may prove to be good candidates for antioxidant therapy to protect against such injury. 2 There is experimental evidence that suggests oxidative damage in pathogenesis of endotoxemia. 3 To evaluate the role of glutathione peroxidase (GP) in protection against endotoxemia in vivo, we have used transgenic mice overexpressing human extracellular (GPxP) and intracellular (GPx1) GP. In the present study, we report that these animals show an increased rate of survival after administration of a large dosage of LPS. Mice with human GPs are able to modulate levels of lipid peroxidation and inflammatory mediators. These transgenic animals represent a new model system for investigation of the role of GPs and reactive oxygen species (ROS) in endotoxemia and other inflammatory disorders.
Materials and Methods
Animals and TreatmentsHeterozygous transgenic mice 5 to 6 months old in a C57BL/ 6ϫCBA/J background overexpressing human GPxP (strain 17) and human GPx1 (strain 23) and their normal littermates were bred in our facility. We described the generation of these mice previously. 4 For survival studies, the mice were injected with LPS at a dose of 25 mg/kg (Escherichia coli serotype 0111:B4; Sigma). Arterial blood pressure and heart rate were measured using the Kent tail blood pressure system. For characterization of cytokine production and leukocyte distribution, blood was collected from the retro-orbital cavity of a group of animals dosed with LPS (16 mg/kg of body weight). Plasma was analyzed for cytokine (tumor necrosis factor-␣ [TNF-␣] and interleukin-1 [IL-1]) production with ELISA kits from R&D Systems. Vascular permeability was determined by assessing tissue accrual of Evan's Blue, as described previously. 5 Sixteen hours after PBS or LPS injection, the animals were administered 25 mg/kg Evan's Blue by tail ...